Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)
Clinical trial NCT03656692 · TERMINATED
Trial details
- NCT number
- NCT03656692
- Sponsor
- Mallinckrodt
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-05
- Primary completion
- 2020-07-14
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.